Matches in Wikidata for { <http://www.wikidata.org/entity/Q95827721> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q95827721 description "article scientifique publié en 2020" @default.
- Q95827721 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95827721 description "scientific article published on 25 May 2020" @default.
- Q95827721 description "wetenschappelijk artikel" @default.
- Q95827721 description "наукова стаття, опублікована 25 травня 2020" @default.
- Q95827721 name "Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer" @default.
- Q95827721 name "Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer" @default.
- Q95827721 type Item @default.
- Q95827721 label "Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer" @default.
- Q95827721 label "Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer" @default.
- Q95827721 prefLabel "Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer" @default.
- Q95827721 prefLabel "Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer" @default.
- Q95827721 P1433 Q95827721-4366C9D9-9E07-4E8E-B9FF-8085FCC94E33 @default.
- Q95827721 P1476 Q95827721-A6142917-1278-4C02-9E14-A06932996F20 @default.
- Q95827721 P2093 Q95827721-16CBE679-EC13-493F-B128-0EA9E0850FE2 @default.
- Q95827721 P2093 Q95827721-33611E7C-3D21-4C51-9A1A-744BB4B344A9 @default.
- Q95827721 P2093 Q95827721-B301F35F-7D66-4F62-8437-345B7242A3F2 @default.
- Q95827721 P2093 Q95827721-D1ADF45D-868F-454E-894A-6CB3DD9AD6C0 @default.
- Q95827721 P2093 Q95827721-DC5A2DF1-5195-4435-B6FE-50DC61568302 @default.
- Q95827721 P2860 Q95827721-CDFC08C4-68FD-485E-9320-9F21588C5D90 @default.
- Q95827721 P2860 Q95827721-D94C5572-6C01-4A4A-BC19-C8B3425E7091 @default.
- Q95827721 P2860 Q95827721-F7A00EF5-3F82-4F5D-853C-520FFF44CCC7 @default.
- Q95827721 P304 Q95827721-CC4D437D-E0DE-4352-97A4-ED4025B62582 @default.
- Q95827721 P31 Q95827721-DD16A943-3C09-4F25-9465-55876AEAC72F @default.
- Q95827721 P356 Q95827721-68337675-B8B5-4F21-A3F5-A087F314E4DA @default.
- Q95827721 P433 Q95827721-D6DC9310-D934-4CE5-A6AD-3F6E04E47336 @default.
- Q95827721 P478 Q95827721-DDB099D8-7139-48CE-9229-EF9D70EF5B07 @default.
- Q95827721 P50 Q95827721-4BF4794E-F515-4A70-9639-F6E1A4342621 @default.
- Q95827721 P577 Q95827721-0921EE40-EF73-4DC8-A8A7-B1EF11F63DA7 @default.
- Q95827721 P698 Q95827721-E84F77A2-5519-4DB3-B3C7-CC8308AA2210 @default.
- Q95827721 P932 Q95827721-988A3AA2-ECB7-4320-A0D4-10673DE30346 @default.
- Q95827721 P356 S12885-020-06885-3 @default.
- Q95827721 P698 32450839 @default.
- Q95827721 P1433 Q326300 @default.
- Q95827721 P1476 "Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer" @default.
- Q95827721 P2093 "Anne-Lise Dechaume" @default.
- Q95827721 P2093 "Bruce C Baguley" @default.
- Q95827721 P2093 "Euphemia Y Leung" @default.
- Q95827721 P2093 "Pamela M Murray" @default.
- Q95827721 P2093 "William P Katt" @default.
- Q95827721 P2860 Q29547693 @default.
- Q95827721 P2860 Q34645070 @default.
- Q95827721 P2860 Q37410615 @default.
- Q95827721 P304 "470" @default.
- Q95827721 P31 Q13442814 @default.
- Q95827721 P356 "10.1186/S12885-020-06885-3" @default.
- Q95827721 P433 "1" @default.
- Q95827721 P478 "20" @default.
- Q95827721 P50 Q90922677 @default.
- Q95827721 P577 "2020-05-25T00:00:00Z" @default.
- Q95827721 P698 "32450839" @default.
- Q95827721 P932 "7333265" @default.